Navigation Links
Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
Date:9/5/2012

of life and resolve serious medical healthcare needs; To identify promising product candidates based on exceptional scientific development expertise, develop our products in a rapid, cost-efficient manner and to pursue commercialization and/or development partners when and where appropriate. We exist to make a difference for the better and these are important times to do that.

Presently, Pharmacyclics has three product candidates in clinical development and several preclinical molecules in lead optimization. The Company is committed to high standards of ethics, scientific rigor, and operational efficiency as it moves each of these programs toward potential commercialization.

The Company is headquartered in Sunnyvale, California and is listed on NASDAQ under the symbol PCYC. To learn more about how Pharmacyclics advances science to improve human healthcare visit us at http://www.pharmacyclics.com.

Contact:Ramses Erdtmann
Vice President of Finance
Phone: 408-215-3325

NOTE: This announcement may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements, among others, relating to our future capital requirements and the sufficiency of our current assets to meet these requirements, our future results of operations, our expectations for and timing of ongoing or future clinical trials and regulatory approvals for any of our product candidates, and our plans, objectives, expectations and intentions. Because these statements apply to future events, they are subject to risks and uncertainties. When used in this announcement, the words "anticipate", "believe", "estimate", "expect", "expectation", "should", "would", "project", "plan", "predict", "intend" and similar expressions are intended to identify such forward-looking stateme
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
2. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
7. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
8. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
9. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
10. Luminex Corporation Reports First Quarter 2012 Results
11. Hospira Reports First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 /PRNewswire/ ... blood glucose device is a home-based electronic device. ... transmitter that transmits information about glucose levels through ... it is displayed. The regular usage of self-monitoring ... and prompt an individual to undergo proper diabetes ...
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 About ... in dryness of eyes due to deficient tear production ... This syndrome is of two types: aqueous tear deficient ... deficient dry eye, lacrimal glands do not produce enough ... eye. Meibomian glands secrete lipids to slow tear evaporation ...
(Date:9/3/2015)... ALISO VIEJO, Calif. , Sept. ... ), a leading global pharmaceutical company, and AqueSys, ... focused on developing ocular implants that reduce intraocular ... they have entered into an agreement under which ...  Under the terms of the agreement, Allergan will ...
Breaking Medicine Technology:Global Self-monitoring Blood Glucose Devices Market 2015-2019 2Global Dry Eye Syndrome Market 2015-2019 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 3Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 4Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 5Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 6
... device to identify the, lipid core (fatty) coronary plaques ... ... Mass., May 15 InfraReDx, Inc. today,announced that physicians at ... Coronary Imaging System in a patient,undergoing a cardiac catheterization. This ...
... BONITA SPRINGS, Fla., May 15 Tigris Pharmaceuticals,Inc. ... and,Development Agreement (CRADA) with the National Cancer Institute ... AFP-464, an,aminoflavone currently in Phase I development. AFP-464 ... resulting in p53 activation and,apoptosis., This is ...
Cached Medicine Technology:First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3
(Date:9/3/2015)... ... 2015 , ... BedJet released a new version of its award winning personal ... the BedJet v2 pre-order campaign blazed past the $1 million dollar mark ... on crowdfunding giant Kickstarter. , Simple to use and beautifully designed, the award winning ...
(Date:9/3/2015)... ... ... Real Time Pain Relief (RTPR), makers of the popular rub-on pain ... an official endorsement deal with the company. Originally from New South Wales, Australia, Mason ... 15. He is an Australian bull riding champion, following in his uncles’ footsteps in ...
(Date:9/3/2015)... ... 03, 2015 , ... Hope For The Warriors® is pleased ... are awarded two times each year to spouses or caregivers of post-9/11 wounded ... to restoring a sense of self, restoring the family unit, and restoring hope ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... graduated compression garments. However, graduated compression garments are an effective solution for reducing ... specialist, Robyn Bjork, was recently sponsored by SIGVARIS for a unique ...
(Date:9/3/2015)... ... 03, 2015 , ... RealtyShares , the online marketplace ... investors to real estate investment opportunities nationwide, today announced that it is introducing ... and sponsoring real estate companies. , These products typically involve investors ...
Breaking Medicine News(10 mins):Health News:BedJet Hits $1 million in Sales in 28 Days on Kickstarter after Shark Tank Rejection 2Health News:BedJet Hits $1 million in Sales in 28 Days on Kickstarter after Shark Tank Rejection 3Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3Health News:Hope For The Warriors Spouse/Caregiver Scholarships Now Open for Spring 2016 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 3Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3
... that may put people with schizophrenia at risk for ... in altered brain activity in schizophrenia is not clear. ... at the University of Pennsylvania have come together using ... unique high-speed imaging technique - to understand how schizophrenia ...
... , THURSDAY, Oct. 13 (HealthDay News) -- Human children are ... a new study finds. Researchers compared the responses of ... Republic of Congo sanctuary. Both the children and the ... own or with a partner. Individuals could pull two ends ...
... Reporter , THURSDAY, Oct. 13 (HealthDay News) -- The symptoms ... come on weekdays, specifically when your child should be heading ... and it can take different forms in many age groups. ... school avoidance "remains a serious problem," said Alan Hilfer, director ...
... This press release is available in Spanish ... Department of Agriculture (USDA) and published recently in the journal ... new varieties of broccoli have not declined since 1975, and ... iron, magnesium, potassium and other minerals that have made the ...
... the International Osteoporosis Foundation (IOF) is releasing a 24-page ... strong muscles. Professor Heike Bischoff-Ferrari, director Centre ... City Hospital and author of the report, stated, "Put ... optimize your bone health by following three essential steps." ...
... exposed to tobacco smoke for a period of months, researchers ... disease (COPD) develops. In the October 14th issue of ... a promising new way to reverse the lung damage underlying ... clear what causes the disease and there has been no ...
Cached Medicine News:Health News:Penn team links schizophrenia genetics to disruption in how brain processes sound 2Health News:Young Children Collaborate Better Than Chimps 2Health News:Why Johnny Won't Go to School 2Health News:Why Johnny Won't Go to School 3Health News:USDA research demonstrates new breeds of broccoli remain packed with health benefits 2Health News:Three steps to unbreakable bones on World Osteoporosis Day 2Health News:Reversing smoke-induced damage and disease in the lung 2
VerdaSee Dock Door Portal ID solutions provide high performance tracking of assets that enter or leave healthcare facilities through dock doors....
The AeroScout Exciter extends the AeroScout system to provide robust and sophisticated RFID detection capabilities....
... Location-ID™ product solutions were developed to assist ... assets. To maximize use of existing capital ... increase the productivity of their employees, organizations ... track their valuable assets and ensure those ...
Radianse indoor positioning supports healthcare asset management with a way to locate medical equipment, devices and other portable assets....
Medicine Products: